Abstract
Pneumonia is a parenchymal lung infection that usually presents with fever and cough and is diagnosed by a new infiltrate on a chest radiograph. Community-acquired pneumonia (CAP) is any pneumonia that is acquired outside of the hospital setting.
Preview
Unable to display preview. Download preview PDF.
References
Fine MJ, Smith MA, Carson CA, et al. Prognosis and outcomes of patients with community-acquired pneumonia: a meta-analysis. JAMA 1996; 275: 134 - 41.
Bernstein JM. Treatment of community-acquired pneumonia-IDSA guidelines. Chest 1999; 115: 95 - 135.
American Thoracic Society. Guidelines for the initial empiric therapy of community-acquired pneumonia. Am J Respir Crit Care Med 2001; 163: 1730 - 54.
British Thoracic Society Research Committee. Community-ac-quired pneumonia in adults in British hospitals in 1982-1983;a survey of aetiology, mortality, prognostic factors and out comes. Q J Med 1987; 62: 195 - 220.
Wipt JE, Lipsky BA, Hirschmann JV, et al. Diagnosing pneumo nia by physical examination. Arch Intern Med 1999; 159: 1082 - 7.
Skerrett SJ. Diagnostic testing for community-acquired pneumonia. Clin Chest Med 1999; 20: 531 - 48.
Fine MJ, Auble TE, Yealy DM, et al. A prediction rule to identify low risk patients with community-acquired pneumonia. NEngl J Med 1997; 336: 243 - 50.
Bartlett JG, Breiman RF, Mandel LA, et al. Community-ac-quired pneumonia in adults: guidelines for management. Clin Infect Dis 1998;26:811-38. 1999; 282: 677 - 86.
Marrie TJ, Lau CY, Wheeler SL, et al. A controlled trial of a critical pathway for treatment of community-acquired pneumonia. JAMA 2000;283:749-55. Care Med 1994; 149: 1359 - 74.
Heffelfinger, JD, Dowell SF, Jorgensen, JH, et al. Management of community-acquired pneumonia in the era of pneumococcal resistance. Arch Intern Med 2000; 160: 1399 - 408.
Mandell LA. Antibiotic therapy for community-acquired pneumonia. Clin Chest Med 1999;20:589-98. 6 ): 1 - 51.
Steinhoff MC, Auerbach BS, Nelson MD, et al. Antibody responses to Haemophilus influenzae type B vaccines in men with human immunodeficiency virus infection. N Engl J Med 1991; 325: 1837-42. 26.
Fang GD, Fine M, Orloff J, et al. New and emerging etiologies for community-acquired pneumonia with implications for ther apy; a prospective multicenter study of 359 cases. Medicine 1990; 69: 307-16. 27.
Block S, Hedrick J, Hammerschlag MR, et al. Mycoplasmal pneumoniae and Chlamydia pneumoniae in pediatric community-acquired pneumonia: comparative efficacy and safety of clarithromycin vs. erythromycin ethylsuccinate. Pediatr J Infect Dis 1995; 14: 471 - 7.
Bartlett JG, Dowell SF, Mandell LA, File TM Jr, Musher DM, Fine MJ. Practice guidelines for the management of community acquired pneumonia. Clin Infect Dis 2000; 31: 347 - 82.
Schliep TC, Yarrish RL. Pneumocystis carinii pneumonia. Semin Respir Infect 1999; 14: 333 - 43.
Goldschmidt RH, Dong BJ. Treatment of AIDS and HIV-related conditions: 2000. J Am Board Fam Pract 2000; 13: 274 - 98.
Wheat J, Sarosi G, McKinsey D, et al. Practice guidelines for the management of patients with histoplasmosis. Clin Infect Dis 2000; 30: 688 - 95.
Stevens D. Coccidioidomycosis. N Engl J Med 1995;16: 1077-82.
Galgiani JN, Ampel NM, Catanzaro A, Johnson RH, Stevens DA, Williams PL. Practice guideline for the treatment of coc-cidioidomycosis. Infectious Diseases Society of America. Clin Infect Dis 2000; 30: 658 - 61.
Dye C, Scheele S, Dolin P, Pathania V, Raviglione MC, for the WHO Global Surveillance and Monitoring Project. JAMA 1999; 282: 677–86.
American Thoracic Society. Treatment of tuberculosis and tuberculosis infection in adults and children. Am J Respir Crit Med 1994; 149: 1359–74.
Chaulk CP, Kazandjian VA, for the Public Health Tuberculosis Guidelines Panel. JAMA 1998; 279: 943 - 8.
American Thoracic Society. Targeted tuberculin testing and treatment of latent tuberculosis infection. MMWR 2000;49(RR-
Slovis BS, Plitman JD, Haas DW. The case against anergy testing as a routine adjunct to tuberculin skin testing. JAMA 2000; 283: 2003 - 7.
Salpeter SR, Sanders GD, Salpeter EE, Owens DK. Monitored isoniazid prophylaxis for low-risk tuberculin reactors older than 35 years of age: a risk benefit and cost-effectiveness analysis. Ann Intern Med 1997; 127: 1051 - 61.
Nolan CM, Goldberg SV, Buskin SE. Hepatotoxity associated with isoniazid preventive therapy: a 7-year survey from a public health tuberculosis clinic. JAMA 1999; 281: 1014 - 8.
Centers for Disease Control. The role of BCG in the prevention and control of tuberculosis in the United States. MMWR 1996; 45 (RR-4): 1 - 18.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2003 Springer Science+Business Media New York
About this chapter
Cite this chapter
Rodnick, J.E., Gude, J.K. (2003). Pulmonary Infections. In: Taylor, R.B., David, A.K., Fields, S.A., Phillips, D.M., Scherger, J.E. (eds) Family Medicine. Springer, New York, NY. https://doi.org/10.1007/978-0-387-21744-4_84
Download citation
DOI: https://doi.org/10.1007/978-0-387-21744-4_84
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4757-5209-0
Online ISBN: 978-0-387-21744-4
eBook Packages: Springer Book Archive